PNV 1.74% $2.26 polynovo limited

Ann: First US Surgeon Podium presentations of Novosorb BTM, page-4

  1. 5,908 Posts.
    lightbulb Created with Sketch. 945
    CEO Paul Brennan said, “To have surgeons of this calibre presenting such a wide variety of clinical applications demonstrates the robust nature of NovoSorb BTM compared with biologic products. We have significant opportunities before us in the market place and the presentations underline our sales push in the US”
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.26
Change
-0.040(1.74%)
Mkt cap ! $1.604B
Open High Low Value Volume
$2.33 $2.34 $2.26 $724.4K 313.3K

Buyers (Bids)

No. Vol. Price($)
8 762 $2.26
 

Sellers (Offers)

Price($) Vol. No.
$2.27 18095 28
View Market Depth
Last trade - 13.18pm 15/07/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.